De novo renal carcinoma arising in non-functional kidney graft: a national retrospective study.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 04 12 2019
accepted: 18 02 2020
pubmed: 29 2 2020
medline: 23 4 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Characteristics of renal carcinoma arising in non-functional graft in renal transplant recipients (RTR) are unknown. We studied a large national retrospective cohort to analyze circumstances of diagnosis, treatment and outcome compared to the literature. Study included all RTR presenting with kidney graft tumors irrespective of the histology, except those with lymphoma and including those tumors arising in non-functional renal graft. Between January 1988 and December 2018, 56,806 patients had renal transplantation in the 32 centers participating in this study. Among this cohort, 18 renal graft tumors were diagnosed in non-functional grafts. The median patient age at the time of diagnosis was 42.1 years (31.7-51.3). Median age of kidney grafts at the time of diagnosis was 56.4 (23.2-63.4). Eight (44.4%) tumors were discovered fortuitously on renal graft histologic analysis. Fourteen tumors (77.8%) were papillary carcinomas. Two patients had clear cell carcinomas and one patient had a pTa high-grade multifocal urothelial carcinoma in the graft of the upper tract with an in situ carcinoma. Renal carcinomas in non-functional grafts are rare entities and most of them are diagnosed fortuitously. Despite the fact that these tumors are small, low grade and with a good prognosis, regular monitoring of non-functional grafts should be performed with at least an annual ultrasonography.

Identifiants

pubmed: 32107673
doi: 10.1007/s11255-020-02422-0
pii: 10.1007/s11255-020-02422-0
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1235-1241

Auteurs

Lionel Vaudreuil (L)

Department of Urology and Renal Transplantation, CHU de Caen, Urology and Transplantation, Avenue de La Côte de Nacre, 14000, Caen, France.

Thomas Bessede (T)

Hôpital Kremlin-Bicêtre, Urology and Transplantation, Paris, France.

Romain Boissier (R)

Hôpital de La Conception, Urology and Transplantation, Marseille, France.

Sébastien Bouye (S)

CHRU de Lille, Urology and Transplantation, Lille, France.

Julien Branchereau (J)

CHU Hôtel Dieu, Urology and Transplantation, Nantes, France.

Kevin Caillet (K)

CHU d'Amiens, Urology and Transplantation, Amiens, France.

François Kleinclauss (F)

CHU de Besançon, Urology and Transplantation, Besançon, France.

Gregory Verhoest (G)

CHU de Rennes, Urology and Transplantation, Rennes, France.

Xavier Tillou (X)

Department of Urology and Renal Transplantation, CHU de Caen, Urology and Transplantation, Avenue de La Côte de Nacre, 14000, Caen, France. xavtillou@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH